Our research will contribute information that highlights cenobamate's potential as a treatment option covering diverse aspects of cenobamate's efficacy, safety, and mechanism of action." ...

Ltd., will present updated data on cenobamate, an anti-seizure medication, at the 2024 American Epilepsy Society (AES) Annual Meeting in Los Angeles, California, December 6-10, 2024. The company ...

Xcopri, the brand name for cenobamate tablets, is a medication heralded by The Canadian Epilepsy Alliance and the Canadian League Against Epilepsy as a promising treatment for partial onset ...